Scarica l'app Stockscreener
128.02
2.81%
-3.70
Dopo l'orario di chiusura:
128.02
Precedente Chiudi:
$131.72
Aprire:
$132.01
Volume 24 ore:
940.85K
Relative Volume:
1.28
Capitalizzazione di mercato:
$7.77B
Reddito:
$3.99B
Utile/perdita netta:
$463.16M
Rapporto P/E:
18.03
EPS:
7.1
Flusso di cassa netto:
$1.10B
1 W Prestazione:
+1.50%
1M Prestazione:
+10.27%
6M Prestazione:
-7.87%
1 anno Prestazione:
+17.84%
Intervallo 1D:
$127.52
$133.00
Intervallo di 1 settimana:
$125.56
$133.00
Portata 52W:
$95.49
$148.06
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
Nome
Jazz Pharmaceuticals Plc
Settore
Industria
Telefono
353-1-634-7800
Indirizzo
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Confronta JAZZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JAZZ
Jazz Pharmaceuticals Plc
|
128.02 | 7.87B | 3.99B | 463.16M | 1.10B | 7.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Iniziato | Deutsche Bank | Buy |
| 2025-03-07 | Aggiornamento | UBS | Neutral → Buy |
| 2025-02-26 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | Iniziato | Goldman | Buy |
| 2024-01-03 | Iniziato | Robert W. Baird | Outperform |
| 2023-11-27 | Downgrade | UBS | Buy → Neutral |
| 2023-09-29 | Iniziato | Raymond James | Mkt Perform |
| 2023-06-12 | Ripresa | Wells Fargo | Equal Weight |
| 2022-12-09 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-06-14 | Iniziato | UBS | Buy |
| 2022-04-06 | Downgrade | Goldman | Buy → Neutral |
| 2021-11-19 | Ripresa | Goldman | Buy |
| 2021-10-07 | Ripresa | Jefferies | Buy |
| 2021-10-05 | Iniziato | Citigroup | Buy |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2021-05-19 | Ripresa | JP Morgan | Overweight |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2021-02-05 | Reiterato | H.C. Wainwright | Buy |
| 2021-02-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-11-03 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-14 | Downgrade | Goldman | Neutral → Sell |
| 2020-09-14 | Ripresa | JP Morgan | Overweight |
| 2020-08-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | Iniziato | Goldman | Neutral |
| 2019-08-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | Iniziato | Barclays | Overweight |
| 2019-03-20 | Iniziato | SunTrust | Buy |
| 2018-12-14 | Iniziato | Wolfe Research | Peer Perform |
| 2018-11-08 | Reiterato | B. Riley FBR | Buy |
| 2018-08-08 | Reiterato | Stifel | Buy |
| 2018-07-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | Reiterato | H.C. Wainwright | Neutral |
| 2018-03-19 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
Mostra tutto
Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie
How to use Fibonacci retracement on Jazz Pharmaceuticals plcMarket Activity Report & Advanced Swing Trade Entry Plans - Newser
Transcript : Jazz Pharmaceuticals plc Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-03-2025 09 - MarketScreener
JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug - MSN
Custom strategy builders for tracking Jazz Pharmaceuticals plcQuarterly Trade Summary & Capital Efficiency Focused Ideas - Newser
Needham & Company LLC Reiterates "Buy" Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ) - MarketBeat
Jazz Pharmaceuticals plc recovery potential after sell offMarket Growth Report & Stepwise Entry/Exit Trade Alerts - Newser
What recovery options are there for Jazz Pharmaceuticals plc2025 Year in Review & Free Expert Verified Stock Movement Alerts - Newser
Measuring Jazz Pharmaceuticals plc’s beta against major indicesGap Down & Weekly Market Pulse Alerts - Newser
Building trade automation scripts for Jazz Pharmaceuticals plc2025 Trading Recap & Daily Profit Maximizing Tips - Newser
Evaluating Jazz Pharmaceuticals plc with trendline analysisWeekly Trading Summary & Real-Time Volume Trigger Notifications - Newser
Will Jazz Pharmaceuticals plc bounce back from current supportJuly 2025 Analyst Calls & Free Daily Entry Point Trade Alerts - Newser
Can Jazz Pharmaceuticals plc recover in the next quarterMarket Growth Summary & Scalable Portfolio Growth Methods - Newser
Can Jazz Pharmaceuticals plc weather a recessionQuarterly Trade Review & AI Enhanced Market Trend Forecasts - khodrobank.com
What the charts say about Jazz Pharmaceuticals plc todayJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser
Published on: 2025-09-02 10:41:13 - Newser
Comparing Jazz Pharmaceuticals plc in custom built stock radarsIndex Update & Free Low Drawdown Momentum Trade Ideas - Newser
Published on: 2025-09-02 05:40:21 - Newser
Jazz Pharmaceuticals (JAZZ) Price Target Raised After Modeyso Commercial Strategy Update - MSN
Will Jazz Pharmaceuticals plc rebound enough to break even2025 AllTime Highs & Low Risk Growth Stock Ideas - Newser
Should you avoid Jazz Pharmaceuticals plc stock right nowWeekly Market Summary & Reliable Price Action Trade Plans - khodrobank.com
Risk vs reward if holding onto Jazz Pharmaceuticals plcQuarterly Market Review & Risk Managed Investment Strategies - Newser
Analyzing recovery setups for Jazz Pharmaceuticals plc investorsWeekly Trend Recap & Comprehensive Market Scan Insights - Newser
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
Published on: 2025-09-01 16:22:28 - beatles.ru
Will Jazz Pharmaceuticals plc price bounce be sustainableJuly 2025 Spike Watch & Free Reliable Trade Execution Plans - Newser
Top chart patterns to watch in Jazz Pharmaceuticals plcJuly 2025 Update & Expert Curated Trade Ideas - Newser
Pattern recognition hints at Jazz Pharmaceuticals plc upsideTrade Risk Assessment & Long-Term Safe Investment Ideas - Newser
Strategies to average down on Jazz Pharmaceuticals plcVolume Spike & Fast Moving Stock Watchlists - Newser
Has Jazz Pharmaceuticals plc formed a bullish divergenceIPO Watch & Reliable Entry Point Alerts - Newser
Is Jazz Pharmaceuticals plc stock entering bullish territory2025 Institutional Moves & Fast Exit and Entry Trade Guides - Newser
Applying chart zones and confluence areas to Jazz Pharmaceuticals plcQuarterly Portfolio Report & Low Volatility Stock Recommendations - Newser
Jazz Pharmaceuticals Plc Azioni (JAZZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):